文献速递常见症状与未分化疾病慢病管理基层心理健康

多发性硬化诊断前处方模式:英国纵向关联数据研究

Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study.
PubMed 文献 · Br J Gen Pract · 2026-04-30

结果显示七类处方均与多发性硬化诊断正相关,诊断前2年比值比最高达3-7倍,且处方率在诊断前数年即出现拐点,提示可能存在早期识别窗口,但置信区间较宽。

要点

  • 多发性硬化诊断前10年内,焦虑/抑郁、偏头痛、下尿路症状、尿路感染、睡眠障碍、胃肠道症状及勃起功能障碍相关处方均更常见。
  • 诊断前2年关联最强,比值比达3-7倍。
  • 处方率拐点出现于诊断前9-72个月不等,但置信区间宽,诊断窗口时长不确定。

核心结论

  • 多发性硬化患者诊断前10年内,针对可能相关症状的处方比对照更常见。
  • 处方率在诊断前数年即发生变化,提示存在更早发现的潜在机会。
  • 诊断窗口时长因置信区间宽而存在不确定性。

研究设计与样本

  • 基于英国常规初级保健数据的病例对照研究。
  • 病例组为2001-2022年确诊多发性硬化的患者,对照组按出生年份匹配。
  • 采用多因素条件逻辑回归调整性别和社会经济状态,分析诊断前0-2年、2-5年、5-10年的处方关联。
  • 采用泊松回归调整年龄、性别和社会经济状态,估计病例组处方率偏离基线的拐点。

主要发现

  • 七类处方与多发性硬化诊断呈正相关,诊断前2年比值比最高达3-7倍。
  • 全处方分析中,胃肠道症状拐点为69-72个月(95%CI 51-90),下尿路症状为69-72个月(95%CI 30-111),尿路感染为66-69个月(95%CI 45-90)。
  • 偏头痛拐点为63-66个月(95%CI 27-102),勃起功能障碍为60-63个月(95%CI 30-93),焦虑/抑郁为9-12个月(95%CI 3-18)。

临床怎么用

  • 全科医生对反复出现焦虑/抑郁、偏头痛、下尿路症状、尿路感染、睡眠障碍、胃肠道症状或勃起功能障碍相关处方的患者,尤其诊断前2年内,可考虑多发性硬化的可能性。
  • 处方率拐点提示诊断前数年即可出现症状相关处方增加,但窗口时长不确定,需结合临床综合判断。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early detection of multiple sclerosis (MS) could improve patient outcomes. Changes in clinical activity before MS diagnosis may represent 'diagnostic windows' for earlier detection. AIM: To determine whether certain prescriptions are more common in patients with MS and examine prescription patterns prediagnosis in the UK. DESIGN AND SETTING: Case-control study using routinely collected primary care data. Patients in the case group had an MS diagnosis (2001-2022) and patients in the control group were matched by birth year. METHOD: Multivariable conditional logistic regression adjusting for sex and socioeconomic status (SES) examined associations between MS diagnosis and prescriptions for anxiety/depression, migraine, lower urinary tract symptoms (LUTS), urinary tract infection (UTI) treatments, sleep disorder, gastrointestinal (GI) symptoms, and erectile dysfunction (ED) in the 0-2, 2-5, 5-10 years prediagnosis/match date. Poisson regression adjusting for age, sex, and SES estimated the inflection points in the case group at which the rate of prescriptions changed from baseline, identifying the start of diagnostic windows. RESULTS: In total, there were 9662 patients in the case group and 56 455 in the control group. Positive associations were found between seven prescriptions and MS diagnosis, with highest odds ratios (3-7 times) in the 2 years prediagnosis. In the all-prescription analysis, inflection points were identified for: GI (69-72 months, 95% confidence interval [CI] = 51 to 90), LUTS (69-72 months, 95% CI = 30 to 111), UTI (66-69 months, 95% CI = 45 to 90), migraine (63-66 months, 95% CI = 27 to 102), ED (60-63 months, 95% CI = 30 to 93), and anxiety/depression (9-12 months, 95% CI = 3 to 18). CONCLUSION: Prescriptions for symptoms of possible MS were more common in the case group than the control group up to 10 years prediagnosis. Prescription rates changed years prediagnosis, indicating potential opportunities for earlier detection, but broad CIs demonstrated uncertainty regarding diagnostic window duration.

来源:Br J Gen Pract,查看原文。版权归原作者所有。

引用

  1. Zhang B, Blyuss O, Arendse KD, et al. Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study. Br J Gen Pract. 2026. PMID: 42009602. doi:10.3399/BJGP.2025.0210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。